XSprayPharma AB Stock: price and insider trades · Sweden
XSprayPharma AB: what insiders have been doing
XSprayPharma AB is a listed company. Its directors and officers file their transactions with Finansinspektionen. The past year has been quiet: not a single insider filing for XSprayPharma AB. The previous disclosure was published on 12 September 2018.
Our records for XSprayPharma AB go back to 2017, with no purchases and 3 sales on the open market in total.
Elsewhere in the same market, our signals recently picked up insider purchases at Dynavox Group AB and Rusta AB (publ). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Financial data
· cache
- 2,000 shares@ SEK 97.27544.1% of flowISIN SE0009973563FI:csv-c517bc7e8be3aef65b9b
- 832 shares@ SEK 60.8911.7% of flowISIN SE0009973563FI:csv-6ab4ced1d38288a4b2d4
- 3,168 shares@ SEK 60.3844.2% of flowISIN SE0009973563FI:csv-1f6a7700dac38dc543d5
- FörvärvISIN XSpray Pharma AB, Transfer of shares due to earn-out agreement with Karolinske Development ABFI:csv-d2deb477e545af023dcf
- FörvärvISIN XSpray Pharma AB, Transfer of shares due to earn-out agreement with KCIF Co-Investment Fund KommanditbolagFI:csv-0e7eeea90da865181263
- TeckningISIN XSprayPharma ABFI:csv-dbf2b99b4e13507a86d1
6 of 6 declarations
About XSprayPharma AB
XSprayPharma AB is a pharmaceutical company focused on developing innovative treatments for respiratory diseases. It is listed on the XSTO market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations